Role of serine/threonine protein phosphatase 2A in cancer

Cancer Letters

Volumn 170, Issue 1, 2001, Pages 1-13

  Schönthal, Axel H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cancer; Protein phosphatase 2A; Tumor suppressor; Tumorigenesis

Indexed keywords

HOLOENZYME; PHOSPHOPROTEIN PHOSPHATASE 2A;

CANCER; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL FUNCTION; CELL GROWTH; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME SUBUNIT; GENE ACTIVATION; GENE TARGETING; GENETIC HETEROGENEITY; GROWTH REGULATION; HUMAN; MUTATION; ONCOGENE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0035840446     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00561-4     Document Type: Review

References (118)

1. Oncogenic signaling
2. Signal transduction
3. Oncogenes and cell proliferation
4. The hallmarks of cancer
5. Signaling - 2000 and beyond
6. Phosphatases and tumorigenesis
7. CDC25 phosphatases as potential human oncogenes
8. PTEN: Life as a tumor suppressor
9. The multiple roles of PTEN in tumor suppression
10. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
11. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity
12. Protein serine/threonine phosphatases - New avenues for cell regulation
13. Regulation of protein kinase cascades by protein phosphatase 2A
14. Protein phosphatase 2A: A panoply of enzymes
15. Role of PP2A in intracellular signal transduction pathways
16. Protein phosphorylation and protein phosphatases. De Panne, Belgium, September 19-24, 1999
17. Novel protein serine/threonine phosphatases: Variety is the spice of life
18. Protein dephosphorylation and the intracellular control of the cell number
19. Calcineurin regulation of the mammalian G0/G1 checkpoint element, cyclin dependent kinase 4
20. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner
21. FIN13, a novel growth factor-inducible serine-threonine phosphatase which can inhibit cell cycle progression
22. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest
23. The novel human protein serine/threonine phosphatase 6 is a functional homologue of budding yeast Sit4p and fission yeast ppe1, which are involved in cell cycle regulation
24. Serine/threonine protein phosphatases
25. Protein serine/threonine phosphatases: Structure, regulation, and functions in cell growth
26. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm
27. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha
28. Saccharomyces cerevisiae homologs of mammalian B and B' subunits of protein phosphatase 2A direct the enzyme to distinct cellular functions
29. Flicking the switches: Phosphorylation of serine/threonine protein phosphatases
30. A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A
31. Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits
32. Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo
33. Physiologic importance of protein phosphatase inhibitors
34. Ceramide activates heterotrimeric protein phosphatase 2A
35. Identification of okadaic acid as a toxic component of marine dinoflagellate
36. Okadaic acid, a cytotoxic polyether from two marine sponges of the genus Halichondria
37. Inhibitory effect of a marine sponge toxin, okadaic acid, on protein phosphatases
38. Okadaic acid: A valuable new tool to study signal transduction and cell cycle regulation?
39. Protein phosphatases come of age
40. Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1
41. AP-1 function and regulation
42. Regulation of gene expression by serine/threonine protein phosphatases
43. Positive and negative regulation of cell cycle progression by serine/threonine protein phosphatases
44. Signal transduction through MAP kinase cascades
45. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
46. Effects of phorbol ester on mitogen-activated protein kinase kinase activity in wild-type and phorbol ester-resistant EL4 thymoma cells
47. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the MAP kinase pathway and induces cell proliferation
48. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
49. Protein serine/threonine phosphatases and cell transformation
50. Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism
51. Okadaic acid and phorbol esters: Comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro
52. The tumor promoters 12-O-tetradecanoylphorbol-13-acetate and okadaic acid differ in toxicity, mitogenic activity and induction of gene expression
53. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis
54. Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis
55. The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells
56. Inhibition of protein phosphatase activity induces p53-dependent apoptosis in the absence of p53 transactivation
57. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A
58. Differential effects of two types of tumor promoters, okadaic acid and 12-O-tetradecanoyl-phorbol-13-acetate, on growth and differentiation of human myeloid leukemia cells
59. Okadaic acid: A reversible inhibitor of neoplastic transformation of mouse fibroblasts
60. The non-phorbol ester tumor promoter okadaic acid does not promote morphological transformation or inhibit junctional communication in hamster embryo cells
61. Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins
62. Analyzing gene expression with the use of serine/threonine phosphatase inhibitors
63. Nuclear protein phosphatase 2A dephosphorylates protein kinase A- phosphorylated CREB and regulates CREB transcriptional stimulation
64. Microinjection and immunological methods in the analysis of type 1 and 2A protein phosphatases from mammalian cells
65. Association of protein phosphatase 2A with polyoma virus medium tumor antigen
66. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A
67. Regulation by tumour antigens defines a role for PP2A in signal transduction
68. Molecular model of the A subunit of protein phosphatase 2A: Interaction with other subunits and tumor antigens
69. Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation
70. Protein phosphatase 2A and the regulation of human papillomavirus gene activity
71. Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts
72. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells
73. Telomerase activity, cell proliferation, and cancer
74. The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A
75. HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint
76. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A
77. Wnt signaling and cancer
78. Reduction of Ha-ras-induced cellular transformation by elevated expression of protein phosphatase type 2A
79. The role of Saccharomyces cerevisiae type 2A phosphatase in the actin cytoskeleton and in entry into mitosis
80. Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A
81. Protein phosphatase 2A is required for the initiation of chromosomal DNA replication
82. PR48, a novel regulatory subunit of protein phosphatase 2A, interacts with Cdc6 and modulates DNA replication in human cells
83. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation
84. Cell cycle targets of Ras/Raf signalling
85. Flat reversion by okadaic acid of raf and ret-II transformants
86. A positive role for the PP2A catalytic subunit in Wnt signal transduction
87. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
88. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2A regulates the activities of G(1) cyclin- dependent kinases
89. Inhibition of histone H1 kinase expression, retinoblastoma protein phosphorylation, and cell proliferation by the phosphatase inhibitor okadaic acid
90. Negative regulation of mitosis by the fission yeast protein phosphatase PPA2
91. Cdc2 H1 kinase is negatively regulated by a type 2A phosphatase in the Xenopus early embryonic cell cycle: Evidence from the effects of okadaic acid
92. Dephosphorylation of cdc25-C by a type-2A protein phosphatase: Specific regulation during the cell cycle in Xenopus egg extracts
93. Inhibition of cdc2 activation by INH/PP2A
94. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways
95. Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling
96. Serine/threonine-specific protein phosphatases and cancer
97. Role of transgenic mice in identification and characterization of tumour suppressor genes
98. PTEN is essential for embryonic development and tumour suppression
99. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
100. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway
101. Phenotypic analysis of human glioma cells expressing the MMAC1 tumor suppressor phosphatase
102. The SIT4 protein phosphatase functions in late G1 for progression into S phase
103. Alterations of the PPP2R1B gene in human lung and colon cancer
104. Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers
105. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms
106. Absence of PPP2R1B gene alterations in primary ovarian cancers
107. Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene
108. Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit of protein phosphatase 2A
109. Comparison of heterotrimeric protein phosphatase 2A containing different B subunits
110. A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation
111. Identification by differential display of a protein phosphatase-2A regulatory subunit preferentially expressed in malignant melanoma cells
112. Protein phosphatases limit tumor motility
113. Regulation of cytoskeletal organization in tumor cells by protein phosphatases-1 and -2A
114. Protein phosphatase-2A association with microtubules and its role in restricting the invasiveness of human head and neck squamous cell carcinoma cells
115. Protein phosphatase-2A associates with the cytoskeleton to maintain cell spreading and reduced motility of nonmetastatic Lewis lung carcinoma cells: The loss of this regulatory control in metastatic cells
116. Endothelial cell response to human head and neck squamous cell carcinomas involves downregulation of protein phosphatases-1/2A, cytoskeletal depolymerization and increased motility